Cancer Risk of Anti-TNF-α at Recommended Doses in Adult Rheumatoid Arthritis: A Meta-Analysis with Intention to Treat and per Protocol Analyses

BACKGROUND: The risk of malignancies on TNF-α antagonists is controversial. The aim of this survey was to assess cancer risk on TNF-α antagonists in adult rheumatoid arthritis patients, including the five marketed drugs (infliximab, etanercept, adalimumab, golimumab and certolizumab) used in line wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Moulis, Guillaume, Sommet, Agnès, Béné, Johana, Montastruc, François, Sailler, Laurent, Montastruc, Jean-Louis, Lapeyre-Mestre, Maryse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3498371/
https://www.ncbi.nlm.nih.gov/pubmed/23155441
http://dx.doi.org/10.1371/journal.pone.0048991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3498371/
https://www.ncbi.nlm.nih.gov/pubmed/23155441
http://dx.doi.org/10.1371/journal.pone.0048991

Ejemplares similares